Show simple item record

dc.contributor.authorSandercock, Peter
dc.contributor.authorLindley, Richard
dc.contributor.authorWardlaw, Joanna
dc.contributor.authorDennis, Martin
dc.contributor.authorInnes, Karen
dc.contributor.authorCohen, Geoff
dc.contributor.authorWhiteley, Will
dc.contributor.authorPerry, David
dc.contributor.authorSoosay, Vera
dc.contributor.authorBuchanan, David
dc.contributor.authorVenables, Graham
dc.contributor.authorCzlonkowska, Anna
dc.contributor.authorKobayashi, Adam
dc.contributor.authorBerge, Eivind
dc.contributor.authorSlot, Karsten Bruins
dc.contributor.authorMurray, Veronica
dc.contributor.authorPeeters, Andre
dc.contributor.authorHankey, Graeme J
dc.contributor.authorMatz, Karl
dc.contributor.authorBrainin, Michael
dc.contributor.authorRicci, Stefano
dc.contributor.authorCantisani, Teresa A
dc.contributor.authorGubitz, Gordon
dc.contributor.authorPhillips, Stephen J
dc.contributor.authorAntonio, Arauz
dc.contributor.authorCorreia, Manuel
dc.contributor.authorLyrer, Phillippe
dc.contributor.authorKane, Ingrid
dc.contributor.authorLundstrom, Erik
dc.contributor.authorIST-3 Collaborative Group
dc.contributor.authorMyint, Phyo Kyaw
dc.date.accessioned2016-01-05T16:12:03Z
dc.date.available2016-01-05T16:12:03Z
dc.date.issued2011-11-30
dc.identifier.citationSandercock , P , Lindley , R , Wardlaw , J , Dennis , M , Innes , K , Cohen , G , Whiteley , W , Perry , D , Soosay , V , Buchanan , D , Venables , G , Czlonkowska , A , Kobayashi , A , Berge , E , Slot , K B , Murray , V , Peeters , A , Hankey , G J , Matz , K , Brainin , M , Ricci , S , Cantisani , T A , Gubitz , G , Phillips , S J , Antonio , A , Correia , M , Lyrer , P , Kane , I , Lundstrom , E , IST-3 Collaborative Group & Myint , P K 2011 , ' Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited ' , Trials , vol. 12 , 252 . https://doi.org/10.1186/1745-6215-12-252en
dc.identifier.issn1745-6215
dc.identifier.otherPURE: 60579439
dc.identifier.otherPURE UUID: 19637e52-b398-4a86-a87a-8267636d7a45
dc.identifier.otherPubMed: 22129158
dc.identifier.otherScopus: 82255173763
dc.identifier.urihttp://hdl.handle.net/2164/5328
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofTrialsen
dc.rights© 2011 Sandercock et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectacute diseaseen
dc.subjectbrain ischemiaen
dc.subjectdouble-blind methoden
dc.subjectfibrinolytic agentsen
dc.subjecthumansen
dc.subjectprospective studiesen
dc.subjectsample sizeen
dc.subjectstrokeen
dc.subjectthrombolytic therapyen
dc.subjecttissue plasminogen activatoren
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleUpdate on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruiteden
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/1745-6215-12-252


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record